Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07094971
What this trial is testing

Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles

Who this might be right for
Muscle ToneMuscle Strength
Sofwave Medical LTD 44
Large-scale testing (Phase 3)Study completedNCT05323734
What this trial is testing

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Who this might be right for
Tuberous Sclerosis Complex
Marinus Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT05014438
What this trial is testing

BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bristol-Myers Squibb 17
Not applicableUnknownNCT06081270
What this trial is testing

Prospective Study on Resistance-associated Mutations in Metastatic Lung Cancer

Who this might be right for
Lung Cancer
University of Milano Bicocca 20
Post-approval studies (Phase 4)Study completedNCT05535595
What this trial is testing

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

Who this might be right for
Hypertension
Yonsei University 77
Not applicableActive Not RecruitingNCT03421977
What this trial is testing

Long-Term Follow-up Study for Patients From AVXS-101-CL-101

Who this might be right for
Spinal Muscular Atrophy 1
Novartis Gene Therapies 13
Early research (Phase 1)Study completedNCT05265767
What this trial is testing

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Who this might be right for
Hemophilia A
Christian Medical College, Vellore, India 6
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Post-approval studies (Phase 4)Study completedNCT04390581
What this trial is testing

Evaluate the Effect of Juvederm Volift With Lidocaine on Aging Hands in Participants Age 35 and Older

Who this might be right for
Skin DepressionsSkin ElasticitySkin Laxity
Allergan 75
Testing effectiveness (Phase 2)Ended earlyNCT02898753
What this trial is testing

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease
Valerion Therapeutics, LLC 12
Not applicableStudy completedNCT00002257
What this trial is testing

Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 150
Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Not applicableNot Yet RecruitingNCT07680751
What this trial is testing

European Cystinosis Cohort 2

Who this might be right for
Cystinosis
Institut National de la Santé Et de la Recherche Médicale, France 250
Not applicableStudy completedNCT01476423
What this trial is testing

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Who this might be right for
Congenital Bleeding DisorderGlanzmann's Disease
Novo Nordisk A/S 218
Large-scale testing (Phase 3)Ended earlyNCT03573882
What this trial is testing

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Who this might be right for
Sickle Cell Disease
Pfizer 179
Not applicableLooking for participantsNCT03718923
What this trial is testing

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Who this might be right for
FOXP1Mental Retardation With Language Impairment and With or Without Autistic FeaturesAutism Spectrum Disorder
Icahn School of Medicine at Mount Sinai 50
Not applicableApproved For MarketingNCT03955679
What this trial is testing

AveXis Managed Access Program Cohort for Access to AVXS-101

Who this might be right for
Spinal Muscular Atrophy
United BioSource, LLC
Testing effectiveness (Phase 2)Study completedNCT03725722
What this trial is testing

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
LEO Pharma 251
Not applicableUnknownNCT04097275
What this trial is testing

Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)

Who this might be right for
Inborn Errors of Metabolism
CENTOGENE GmbH Rostock 1,000
Next Page